MRI CHANGES IN NEWLY DIAGNOSED GLIOBLASTOMA PATIENTS TREATED AS PART OF A PHASE II TRIAL WITH BAVITUXIMAB, RADIATION, AND TEMOZOLOMIDE

被引：0
|
作者：
Ly, Ina [1 ]
Cardona, Jonathan [2 ]
Beers, Andrew [2 ]
Chang, Ken [2 ]
Brown, James [2 ]
Reardon, David [3 ]
Arrillaga-Romany, Isabel [4 ]
Dietrich, Jorg [1 ]
Forst, Deborah [1 ]
Lee, Eudocia [3 ]
Jordan, Justin [5 ]
Nayak, Lakshmi [3 ]
Wen, Patrick [6 ]
Batchelor, Tracy [4 ]
Kalpathy-Cramer, Jayashree [7 ]
Gerstner, Elizabeth [1 ]
机构：
[1] Massachusetts Gen Hosp, Boston, MA 02114 USA
[2] Massachusetts Gen Hosp, Athinoula A Martinos Ctr Biomed Imaging, Charlestown, MA USA
[3] Dana Farber Canc Inst, Boston, MA 02115 USA
[4] Harvard Med Sch, Massachusetts Gen Hosp, Boston, MA 02115 USA
[5] Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA
[6] Harvard Med Sch, Dana Farber Canc Inst, Boston, MA 02115 USA
[7] Athinoula A Martinos Ctr Biomed Imaging, Boston, MA USA
来源：
NEURO-ONCOLOGY | 2018年 / 20卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
NIMG-68
引用
收藏
页码：191 / 191
页数：1
相关论文
共 50 条
  • [31] Phase II trial of concurrent sunitinib, temozolomide, and radiotherapy with adjuvant temozolomide for newly diagnosed MGMT unmethylated glioblastoma
    Faye, Mame Daro
    Easaw, Jacob
    De Robles, Paula
    Agnihotram, Raman
    Torres-Vasquez, Alexander
    Lamonde, Frederic
    Petrecca, Kevin
    Owen, Scott
    Panet-Raymond, Valerie
    Shenouda, George
    Souhami, Luis
    Azam, Maryam
    Hossain, Bushra
    Alkass, Jad
    Sabri, Siham
    Abdulkarim, Bassam
    NEURO-ONCOLOGY ADVANCES, 2023, 5 (01)
  • [32] Phase I/II study of pazopanib and temozolomide in patients with newly diagnosed and resected glioblastoma: Pazoglio trial.
    Saada-Bouzid, Esma
    Frenel, Jean-Sebastien
    Augereau, Paule
    Bourg, Veronique
    Gal, Jocelyn
    Jacquinot, Rique
    Gourmelon, Carole
    Chateau, Yann
    Barriere, Jerome
    Bondiau, Pierre-Yves
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [33] Glasdegib in combination with temozolomide and radiotherapy in patients with newly diagnosed glioblastoma: Phase Ib/II GEINO 1602 trial
    Vaz, M. A.
    del Barco, S.
    Sepulveda, J. M.
    Alonso, M.
    Pineda, E.
    Balana, C.
    Martinez-Garcia, M.
    Girones, R.
    ANNALS OF ONCOLOGY, 2023, 34 : S393 - S393
  • [34] AVASTIN AND TEMOZOLOMIDE FOLLOWING RADIATION AND CHEMOTHERAPY FOR NEWLY DIAGNOSED GLIOBLASTOMA: RESULTS OF A PHASE II STUDY
    Nicholas, M. K.
    Chmura, S.
    Paleologos, Nina
    Krouwer, Hendrikus
    Malkin, Mark
    Junck, Larry
    Vick, Nicholas A.
    Lukas, Rimas V.
    NEURO-ONCOLOGY, 2011, 13 : 88 - 89
  • [35] A PHASE I STUDY OF SORAFENIB WITH RADIATION AND TEMOZOLOMIDE IN NEWLY DIAGNOSED GLIOBLASTOMA
    Colman, Howard
    Gilbert, Mark
    Yung, W. K. Alfred
    Aldape, Ken
    De Groot, John
    Conrad, Charles
    Levin, Victor
    Groves, Morris
    Loghin, Monica
    Chris, Pelloski
    Puduvalli, Vinay
    NEURO-ONCOLOGY, 2011, 13 : 61 - 61
  • [36] Late Radiation Outcomes of Patients with Newly Diagnosed Glioblastoma Treated with Accelerated Hyperfractionated Radiotherapy and Temozolomide
    Ergen, Sefika Arzu
    Meral, Rasim
    Altun, Musa
    TURK ONKOLOJI DERGISI-TURKISH JOURNAL OF ONCOLOGY, 2019, 34 (01): : 27 - 35
  • [37] Survival of Patients with Newly Diagnosed Glioblastoma Treated with Radiation and Temozolomide in Research Studies in the United States
    Grossman, Stuart A.
    Ye, Xiaobu
    Piantadosi, Steven
    Desideri, Serena
    Nabors, Louis B.
    Rosenfeld, Myrna
    Fisher, Joy
    CLINICAL CANCER RESEARCH, 2010, 16 (08) : 2443 - 2449
  • [38] PHASE II TRIAL OF UPFRONT BEVACIZUMAB WITH TEMOZOLOMIDE AND RADIATION THERAPY FOLLOWED BY BEVACIZUMAB, TEMOZOLOMIDE AND ORAL TOPOTECAN FOR NEWLY DIAGNOSED GLIOBLASTOMA MULTIFORME (GBM)
    Ranjan, Tulika
    Desjardins, Annick
    Peters, Katherine B.
    Alderson, Lloyd
    Kirkpatrick, John
    Herndon, James, II
    Bailey, Leighann
    Sampson, John
    Friedman, Allan H.
    Friedman, Henry
    Vredenburgh, James J.
    NEURO-ONCOLOGY, 2012, 14 : 79 - 79
  • [39] A phase II trial of lithium, bevacizumab, temozolomide, and radiation for newly diagnosed glioblastomas (GBM).
    Narayana, Ashwatha
    Tam, Moses M.
    Gruber, Deborah Beth
    Golfinos, John
    Parker, Erik
    Zagzag, David
    Gruber, Michael L.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [40] Phase II study of temozolomide, thalidomide, and celecoxib for newly diagnosed glioblastoma
    Wen, PY
    Gigas, DC
    MacDonald, L
    Batchelor, TT
    Schiff, D
    Xu, R
    Ramakrishna, N
    Weaver, S
    Kracher, J
    Bradshaw, J
    Levy, B
    Bailey, E
    Kesari, S
    Maher, EA
    Henson, J
    Black, PM
    NEURO-ONCOLOGY, 2004, 6 (04) : 385 - 385
12345